Evidence map›Paper›PMID 32606660›Full record

ArticleInternational journal of nanomedicine2020

Biosynthesis of Copper Oxide Nanoparticles with Potential Biomedical Applications.

Navid Rabiee, Mojtaba Bagherzadeh, Mahsa Kiani, Amir Mohammad Ghadiri, Fatemeh Etessamifar, Amir Hossein Jaberizadeh, Alireza Shakeri

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
6.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 132 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Biogenic copper and copper oxide nanoparticles to combat multidrug-resistantBiotechnology reports (Amsterdam, Netherlands) · 2025
    Review
  7. Article
  8. Zaluzanin-D enrichedRSC advances · 2024
    Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Navid RabieeDepartment of Chemistry, Sharif University of Technology, Tehran 11155-3516, Iran.ORCID 0000-0002-6945-8541
Mojtaba BagherzadehDepartment of Chemistry, Sharif University of Technology, Tehran 11155-3516, Iran.
Mahsa KianiDepartment of Chemistry, Sharif University of Technology, Tehran 11155-3516, Iran.
Amir Mohammad GhadiriSchool of Chemistry, College of Science, University of Tehran, Tehran, Iran.ORCID 0000-0003-4393-5837
Fatemeh EtessamifarDepartment of Chemistry, Sharif University of Technology, Tehran 11155-3516, Iran.ORCID 0000-0001-5441-9366
Amir Hossein JaberizadehSchool of Chemistry, College of Science, University of Tehran, Tehran, Iran.
Alireza ShakeriSchool of Chemistry, College of Science, University of Tehran, Tehran, Iran.
Sharif University of Technology · IRUniversity of Tehran · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIn recent years, the use of cost-effective, multifunctional, environmentally friendly and simple prepared nanomaterials/nanoparticles have been emerged considerably. In this manner, different synthesizing methods were reported and optimized, but there is still lack of a comprehensive method with multifunctional properties. MATERIALS AND

methodsIn this study, we aim to synthesis the copper oxide nanoparticles using

resultsBased on our knowledge, this is a comprehensive study on the catalytic and biological activity of copper oxide nanoparticles synthesizing from

conclusionComprehensive biomedical and catalytic investigation of the biosynthesized CuO-NPs showed the mentioned method leads to synthesis of more eco-friendly nanoparticles. The in vitro studies showed promising and considerable results, and due to the great stability of these nanoparticles in a green media, effective biological activity considered as an advantageous.

Indexed as

Biomedical TechnologyAchilleaAnti-Bacterial AgentsAntifungal AgentsBacteriaCatalysisCell SurvivalCopperCycloaddition ReactionFungiHep G2 CellsHumansMetal NanoparticlesMicrobial Sensitivity TestsPlant ExtractsSolventsAnti-Bacterial AgentsAntifungal AgentsCoppercuprous oxidePlant ExtractsSolventsantibacterial activityantifungal activitycatalytic activitycopper oxide nanoparticlesgreen synthesis

Identifiers

PMID32606660
PMCPMC7294052
OpenAlexW3033851649

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.